GeoVax Labs Files 8-K on Financials
Ticker: GOVX · Form: 8-K · Filed: Jul 29, 2025 · CIK: 832489
Sentiment: neutral
Topics: financial-condition, results-of-operations, filing
Related Tickers: GOVX
TL;DR
GeoVax Labs dropped its 8-K on July 28th, check the financials.
AI Summary
On July 28, 2025, GeoVax Labs, Inc. filed an 8-K report detailing results of operations and financial condition. The filing includes financial statements and exhibits, providing an update on the company's financial status. The report was officially filed with the SEC on July 29, 2025.
Why It Matters
This filing provides investors with crucial, up-to-date information on GeoVax Labs' financial performance and operational status, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- GeoVax Labs, Inc. (company) — Registrant
- July 28, 2025 (date) — Earliest event reported
- July 29, 2025 (date) — Filing date
- 001-39563 (other) — SEC File Number
- 87-0455038 (other) — EIN
FAQ
What specific financial information is being reported in this 8-K?
The 8-K filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported is dated July 28, 2025.
What is the SEC file number for GeoVax Labs, Inc.?
The SEC file number for GeoVax Labs, Inc. is 001-39563.
What is the company's Employer Identification Number (EIN)?
The company's EIN is 87-0455038.
What is the standard industrial classification for GeoVax Labs, Inc.?
The standard industrial classification for GeoVax Labs, Inc. is PHARMACEUTICAL PREPARATIONS [2834].
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 29, 2025 regarding GeoVax Labs, Inc. (GOVX).